GeneDx (WGS) announced the appointment of Lisa Gurry as Chief Business Officer, CBO, effective immediately. In this newly-created role, Gurry will lead GeneDx’s next phase of transformation, advancing data and information services across biopharma, health systems, and other partners to accelerate the company’s long-term vision.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WGS:
- Eli Lilly’s (LLY) AI Chief Joins the Board of GeneDx
- GeneDx Holdings Appoints Thomas Fuchs to Board
- GeneDx price target raised to $140 from $120 at Piper Sandler
- Cathie Wood ‘Buys the Dip’ in Robinhood, CRISPR, and Beam Therapeutics Stocks
- Cathie Wood Pours Over $46M into Biotech Stocks, 8/19/2025